HighRes Biosolutions is a global laboratory automation company founded in 2004. It aims to enhance productivity for scientists by creating data factories through the connection of instrumentation with informatics. The company's hardware, powered by Cellario™, a robust laboratory software, allows immediate adaptation to evolving scientific, technological, and organizational needs. HighRes invites scientists to design, build, and test experiments, streamlining sample management across single and multiple Work Cells.
HighRes Biosolutions' recent $2.48M Venture Round investment in July 21, 2015 has facilitated its mission to revolutionize laboratory automation. The company operates in the fields of Biotechnology, Robotics, and Construction. With its headquarters in the United States, HighRes is leading the way in total laboratory automation, keeping pace with the rapid evolution of science. With no information provided regarding the specific investors in the latest investment round, HighRes Biosolutions continues to innovate and shape the future of lab automation.